Pfizer’s honesty has been called into question after whistleblowers involved in the original trial came forward with a series of concerns about how the trial was managed as published in the BMJ.
Pfizer’s honesty has been called into question after whistleblowers involved in the original trial came forward with a series of concerns about how the trial was managed as published in the BMJ.